Mandana Khalili, MD

Professor in Residence

POSITIONS:
Chief of Clinical Hepatology, San Francisco General Hospital
Director, Clinical and Translational Research in Hepatology, San Francisco General Hospital
Director, Investigator Development Unit, UCSF Research Coordinating Center to Reduce Disparities in Multiple Chronic Diseases (Health Equity Action Network)
Co-Director, UCSF Mentor Training Program
Co-Director, UCSF T32 Hepatology Training Program
Editorial board member, Hepatology Journal

RESEARCH PROGRAM:
Mandana Khalili is a Professor of Medicine in the Department of Medicine and Chief of Clinical Hepatology at Zuckerberg San Francisco General Hospital (ZSFG). She also serves as the Director of Clinical and Translational Research in Hepatology at ZSFG. Her research focuses on assessing and addressing health disparities related to viral hepatitis, nonalcoholic fatty liver disease, alcohol-associated liver disease, cirrhosis, and hepatocellular carcinoma including natural history, pathogenesis, metabolic complications, healthcare access and novel treatments. She has a longstanding track record of extramural funding in these areas and has served as PI or co-PI of several NIH-sponsored national and international networks. She currently serves as a PI for the NIDDK-sponsored Liver Cirrhosis Network and also Hepatitis B Research Network assessing the natural history and optimal management of patients with hepatitis B and cirrhosis. Her group previously evaluated mechanisms of insulin resistance and secretion in Latinos with and without hepatitis C infection and is now examining how alcohol affects insulin action and adipose tissue insulin resistance among this at high-risk populations. In collaboration with two VA hospitals, she is evaluating the impact of COVID pandemic and transitions in care delivery on telemedicine satisfaction, quality of life, cirrhosis management, liver cancer screening and substance use among vulnerable populations in order to implement measures and policies to provide equitable liver care. Her group is also evaluating alcohol treatment in patients with liver disease using a novel stepped care motivational interviewing and addiction medicine treatment in the hepatology setting. Additional studies include examining patient and provider knowledge, attitudes and barriers to viral hepatitis and fatty liver disease management and implementing novel patient-centered as well as provider interventions such as education through mobile app to enhance patient care and address barriers to care. Her group’s recent efforts in developing an integrated model of shelter-based hepatitis C screening and treatment within large homeless shelters in San Francisco and Minnesota has been successful in scaling up hepatitis C management in persons who inject drugs and homeless residents. She is a member of the Liver Cancer San Francisco Cancer Initiative (SF-CAN), which in partnership with the City and County of San Francisco and other health and community partners, is using interventional strategies to reduce cancer in the city. Dr. Khalili is passionate about mentoring trainees and junior faculty and she has mentored numerous trainee and faculty at all career stages. She is a recipient of a NIH-sponsored K24 award in mentoring junior investigators in liver disease and the co-Director (co-PI) of the T32 Training in Hepatology. She has campus wide leadership roles in mentoring as the Director of UCSF Mentor Training Program. She also currently serves as the Director of Investigator Development Unit of the Research Coordinating Center to Reduce Disparities in Multiple Chronic Diseases sponsored by NIMHD. Her diverse research program including translational research, natural history and epidemiology, community/participatory research, health services/disparity, and clinical trials provides the infrastructure for supporting junior investigators and in transitioning them to independence.

WEBSITES
https://health-equity-action.org/
http://ctsi.ucsf.edu/about-us/team/programs/career-development-cd
http://accelerate.ucsf.edu/training/mdp-people
http://livercenter.ucsf.edu/members/mkhalili.html
http://ctsi.ucsf.edu/news/about-ctsi/driving-excellence-mentoring-ucsf

Education
2022 - Diversity, Equity, and Inclusion Champion Training, University of California San Francisco
Mentor Development Program Certificate, 2007 - Research Mentoring, UCSF
M.A.S, 2005 - Masters in Advanced Studies in Clinical and Epidemiologic Research, UCSF
Transplant Hepatology, 1999 - Transplant Hepatology and Post-Doctoral Research, UCSF
Hepatology, 1998 - Hepatology, Ochsner Clinic
Gastroenterology, 1997 - Gastroenterology, McGill University
M.D., 1992 - Medicine, University of Ottawa
Honors and Awards
  • Harold L. Luft Award, Health Disparity Mentoring Award Nomination, UCSF, 2023
  • UCSF Helen Diller Family Comprehensive Cancer Center, Cancer Control Branch, Member, UCSF, 2023
  • ZSFG Department of Medicine Mentoring Award, UCSF, 2023
  • Zuckerberg San Francisco DOM Physician COVID-19 Clinical Service Recognition Award, UCSF, 2022
  • Affiliate Faculty, UCSF Philip R. Lee Institute for Health Policy Studies, 2022
  • Visiting Professor, Department of Scientific Research, Peking Union Medical College, Beijing, China, 2019
  • Certificate of Appreciation-Mentor Training Program, Peking Union Medical College, Beijing, China, 2018
  • Harold L. Luft Award, Health Disparity Mentoring Award Nomination, UCSF, 2017
  • ZSFG Distinction in Medical Education Award Nomination, UCSF, 2016
  • Academic Senate Distinction in Mentoring Award Nomination, UCSF, 2015
  • Mid-Career Investigator Award in Patient Oriented Research, NIH, 2014
  • Academic Senate Distinction in Mentoring Award Nomination, UCSF, 2013
  • UCSF University Community Partnerships Council Service Learning Award, UCSF, 2009
  • Longitudinal Clinical Experience Appreciation Certificate, UCSF, 2008
  • Recognizing Discovery and Innovation in 2001: Milestones in Hepatitis C, Hepatitis Innovation Award, Schering Oncology, 2001
  • American Digestive Health Foundation, Martin Brotman Training and Transition Award, Gastroenterology Research Group, 2000
  • Natural Sciences and Engineering Research Council Award, Canada, 1988
  • J.W. McConnell Entrance Award, McGill University, 1986
Websites
Publications

  1. Patel Shyam,
    Partida Diana,
    Magee Catherine,
    Garza Romero Flor E.,
    Chen Jennifer Y.,
    Tana Michelle,
    Khalili Mandana. Steatotic Liver Disease Education Enhances Knowledge and Confidence to Adhere to Provider Recommendations in Diverse and Vulnerable Populations Gastro Hep Advances 2024. PMID:


  2. Satre DD, Dasarathy D, Batki SL, Ostacher MJ, Snyder HR, Hua W, Parekh P, Shui AM, Cheung R, Monto A, Wong RJ, Chen JY, Liao M, Tana M, Chen P-H, Haight C G, Fakadej T, Khalili M. Factors Associated With Motivation to Reduce Alcohol Use Among Patients With Chronic Liver Disease Alimentary pharmacology & therapeutics 2024. PMID:


  3. Satre DD, Dasarathy D, Batki SL, Ostacher MJ, Snyder HR, Hua W, Parekh P, Shui AM, Cheung R, Monto A, Wong RJ, Chen JY, Liao M, Tana M, Chen PH, Haight CG, Fakadej T, Khalili M. Factors Associated With Motivation to Reduce Alcohol Use Among Patients With Chronic Liver Disease. Alimentary pharmacology & therapeutics 2024. PMID: 39523996


  4. Murnane PM, Afshar M, Chamie G, Cook RL, Ferguson T, Haque LY, Jacobson KR, Justice AC, Kim TW, Khalili M, Krupitsky E, McGinnis KA, Molina P, Muyindike WR, Myers B, Richards VL, So-Armah K, Stewart S, Sulkowski MS, Tien PC, Hahn JA. Using phosphatidylethanol as an adjunct to self-reported alcohol use improves identification of liver fibrosis risk. The American journal of gastroenterology 2024. PMID: 39480054


  5. Klepper A, Kung A, Vazquez SE, Mitchell A, Mann S, Zorn K, Avila-Vargas I, Kari S, Tekeste M, Castro J, Lee B, Duarte M, Khalili M, Yang M, Wolters P, Price J, Perito E, Feng S, Maher JJ, Lai J, Weiler-Normann C, Lohse AW, DeRisi J, Tana M. Novel autoantibody targets identified in patients with autoimmune hepatitis (AIH) by PhIP-Seq reveals pathogenic insights. medRxiv : the preprint server for health sciences 2023. PMID: 37398174


  6. J. Flanary
    E. A. King
    F. N. U. Baimaji
    A. T. Strauss
    N. Welch
    A. Bellar
    C. B. Sherman
    B. Hameed
    M Khalili
    S Dasarathy
    A.M. Cameron
    P-H. Chen. Recipients of Early Liver Transplants for Alcohol-Related Liver Disease May Reside in Areas with Lower Social Vulnerability. Gastro Hep Advances, DOI: 10.1016/j.gastha.2024.08.020, https://doi.org/10.1016/j.gastha.2024.08.020 2024. PMID:


  7. Erlandson KM, Geng LN, Selvaggi CA, Thaweethai T, Chen P, Erdmann NB, Goldman JD, Henrich TJ, Hornig M, Karlson EW, Katz SD, Kim C, Cribbs SK, Laiyemo AO, Letts R, Lin JY, Marathe J, Parthasarathy S, Patterson TF, Taylor BD, Duffy ER, Haack M, Julg B, Maranga G, Hernandez C, Singer NG, Han J, Pemu P, Brim H, Ashktorab H, Charney AW, Wisnivesky J, Lin JJ, Chu HY, Go M, Singh U, Levitan EB, Goepfert PA, Nikolich JŽ, Hsu H, Peluso MJ, Kelly JD, Okumura MJ, Flaherman VJ, Quigley JG, Krishnan JA, Scholand MB, Hess R, Metz TD, Costantine MM, Rouse DJ, Taylor BS, Goldberg MP, Marshall GD, Wood J, Warren D, Horwitz L, Foulkes AS, McComsey GA, RECOVER-Adult Cohort. Differentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort. Annals of internal medicine 2024. PMID: 39133923


  8. Tapper EB, Goldberg D, Parikh ND, Terrault NA, Welch N, Sharpton S, Hameed B, Khalili M, Stolz A, Verna EC, Brown RS, Sanyal AJ, VanWagner L, Ladner DP, Moylan CA, Diehl AM, Jones PD, Loomba RC, Dasarathy S, Simonetto DA, Shah VH, Bajaj JS, LCN Study Group. The Liver Cirrhosis Network Cohort Study: Cirrhosis Definition, Study Population, and Endpoints. The American journal of gastroenterology 2024. PMID: 39018024


  9. Ghany MG, King WC, Hinerman AS, Lok ASF, Lisker-Melman M, Chung RT, Terrault N, Janssen HLA, Khalili M, Lee WM, Lau DTY, Cloherty GA, Sterling RK. REPLY: The exact predictive value of HBcrAg and HBV RNA in serological status and disease activity in CHB. Hepatology (Baltimore, Md.) 2024. PMID: 38861678


  10. Wong RJ, Jones PD, Niu B, Therapondos G, Thamer M, Kshirsagar O, Zhang Y, Pinheiro P, Kyalwazi B, Fass R, Khalili M, Singal AG. Clinician-Level Knowledge and Barriers to Hepatocellular Carcinoma Surveillance. JAMA network open 2024. PMID: 38743424


  11. Luk JW, Satre DD, Cheung R, Wong RJ, Monto A, Chen JY, Batki SL, Ostacher MJ, Snyder HR, Shui AM, Liao M, Haight CG, Khalili M. Problematic alcohol use and its impact on liver disease quality of life in a multicenter study of patients with cirrhosis. Hepatology communications 2024. PMID: 38315141


  12. Feuille C, Kari S, Patel R, Oberoi R, Liu J, Ohliger M, Khalili M, Tana M. Utility and impact of magnetic resonance elastography in the clinical course and management of chronic liver disease. Scientific Reports 2024. PMID: 38242967


  13. Kim RG, Patel S, Satre DD, Shumway M, Chen JY, Magee C, Wong RJ, Monto A, Cheung R, Khalili M. Telehepatology Satisfaction Is Associated with Ethnicity: The Real-World Experience of a Vulnerable Population with Fatty Liver Disease. Digestive diseases and sciences 2024. PMID: 38217682


  14. Choi HH, Kim S, Shum DJ, Huang CY, Shui A, Fox RK, Khalili M. Assessing Adherence to US LI-RADS Follow-up Recommendations in Vulnerable Patients Undergoing Hepatocellular Carcinoma Surveillance. Radiology. Imaging cancer 2024. PMID: 38214600


  15. Wong RJ, Yang Z, Ostacher M, Zhang W, Satre D, Monto A, Khalili M, Singal AK, Cheung R. Alcohol Use Patterns During and After the COVID-19 Pandemic Among Veterans in the United States. The American journal of medicine 2023. PMID: 38052382


  16. Athavale P, Wong RJ, Satre DD, Monto A, Cheung R, Chen JY, Batki SL, Ostacher MJ, Snyder HR, Widiarto BD, Oh SY, Liao M, Viviani AML, Khalili M. Telehepatology Use and Satisfaction Among Vulnerable Cirrhosis Patients Across Three Healthcare Systems in the Coronavirus Disease Pandemic Era. Gastro Hep Advances 2023. PMID: 39129958


  17. Evon DM, Lin HS, Khalili M, Wahed AS, Yim C, Fontana RJ, Hoofnagle JH, Hepatitis B Research Network (HBRN). Symptoms of Liver Disease During Tenofovir Therapy With or Without Peginterferon: Results from the Hepatitis B Research Network Immune Active Trial. Digestive diseases and sciences 2023. PMID: 37804353


  18. Patel S, Kim RG, Shui AM, Magee C, Lu M, Chen J, Tana M, Huang CY, Khalili M. Fatty Liver Education Promotes Physical Activity in Vulnerable Groups, Including Those With Unhealthy Alcohol Use. Gastro Hep Advances 2023. PMID: 39100862


  19. Medina SP, Kim RG, Magee C, Stapper N, Khalili M. Cross-sectional study on stigma and motivation to adhere to lifestyle modification among vulnerable populations with fatty liver disease. Obesity science & practice 2023. PMID: 38090690


  20. Lisker-Melman M, King WC, Ghany MG, Chung RT, Hinerman AS, Cloherty GA, Khalili M, Jain MK, Sulkowski M, Sterling RK. Human immunodeficiency virus coinfection differentially impacts hepatitis B virus viral markers based on hepatitis Be antigen status in patients with suppressed viremia. Journal of viral hepatitis 2023. PMID: 37278302


  21. Ghany MG, King WC, Hinerman AS, Lok AS, Lisker-Melman M, Chung RT, Terrault N, Janssen HLA, Khalili M, Lee WM, Lau DTY, Cloherty GA, Sterling RK. Use of HBV RNA and hepatitis B core-related antigen to predict change in serological status and disease activity in CHB. Hepatology (Baltimore, Md.) 2023. PMID: 37074026


  22. Kleiner DE, Lisker-Melman M, Wahed AS, Bhan AK, Nalesnik MA, Choi EK, Leonard KK, Ghany MG, Chung RT, Di Bisceglie AM, Hepatitis B Research Network. Immunostaining for hepatitis B viral antigens in liver: Association with clinical, biochemical, and virologic features of disease. Journal of gastroenterology and hepatology 2023. PMID: 36890337


  23. Khalili M, Leonard KR, Ghany MG, Hassan M, Roberts LR, Sterling RK, Belle SH, Lok AS, Hepatitis B Research Network. Racial Disparities in Treatment Initiation and Outcomes of Chronic Hepatitis B Virus Infection in North America. JAMA network open 2023. PMID: 37036707


  24. Feld JJ, Wahed AS, Fried M, Ghany MG, Di Bisceglie AM, Perrillo RP, Khalili M, Yang X, Belle SH, Janssen H, Terrault N, Lok AS, Hepatitis B Research Network (HBRN). Withdrawal of long-term nucleotide analogue therapy in chronic hepatitis B: Outcomes from the withdrawal phase of the HBRN immune active treatment trial. The American journal of gastroenterology 2023. PMID: 36728214


  25. Khalili M, Kim NJ, Tsoh JY, Walsh JME, Elizabeth Goldman L, Park H, Lau I, Wong C, Gildengorin G, Nguyen TT. Efficacy of a Primary Care-Based Mobile Application to Increase Hepatitis C Screening Among Asian Americans: A Secondary Analysis of a Randomized Clinical Trial. Open forum infectious diseases 2023. PMID: 36726551


  26. Terrault NA, Lok AS, Wahed AS, Ghany MG, Perrillo RP, Fried MW, Wong DK, Khalili M, Lau DTY, Sterling RK, Di Bisceglie AM, Lisker-Melman M, Cooper SL, Chung RT, Patel K, Roberts LR, Belle SH, Janssen HLA, Hepatitis B Research Network. Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B. The American journal of gastroenterology 2023. PMID: 36599136


  27. Cheng YW, McLean R, Sewell JL, Huang CY, Khalili M. Inflammatory bowel disease type influences development of elevated liver enzymes. JGH open : an open access journal of gastroenterology and hepatology 2022. PMID: 36514498


  28. Kim RG, Deng J, Reaso JN, Grenert JP, Khalili M. Noninvasive Fibrosis Screening in Fatty Liver Disease Among Vulnerable Populations: Impact of Diabetes and Obesity on FIB-4 Score Accuracy. Diabetes care 2022. PMID: 35947698


  29. Kim RG, Khalili M. Undiagnosed abnormal alanine transaminase levels in vulnerable populations: Impact of sex, race/ethnicity, and body mass. Obesity science & practice 2022. PMID: 37034566


  30. Kim RG, Chu JN, Vittinghoff E, Deng J, Reaso JN, Grenert JP, Khalili M. Racial/ethnic differences in fibrosis prevalence and progression in biopsy-proven steatosis: A focus on the Asian American population. Hepatology communications 2022. PMID: 36087033


  31. Lisker-Melman M, Wahed AS, Ghany MG, Chung RT, King WC, Kleiner DE, Bhan AK, Khalili M, Jain MK, Sulkowski M, Wong DK, Cloherty G, Sterling RK. HBV Transcription and Translation Persist Despite Viral Suppression in HBV-HIV Co-Infected Patients on Antiretroviral Therapy. Hepatology (Baltimore, Md.) 2022. PMID: 35770681


  32. Feld JJ, King WC, Ghany MG, Chang KM, Terrault N, Perrillo RP, Khalili M, Hinerman AS, Janssen H, Lok AS, Hepatitis B Research Network (HBRN). Characteristics of older patients with immunotolerant chronic hepatitis B virus infection. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2022. PMID: 35843468


  33. King WC, Sterling RK, Hinerman AS, Lok ASF, Cloherty GA, Ghany MG, HBRN HBV Novel Assays Group (Corporate authorship), Wahed AS, Chung RT, Janssen HLA, Khalili M, Lau DTY, Lee WM, Lisker-Melman M, Terrault N. Hepatitis B RNA and Core-related Antigen Provide Value Beyond DNA in Evaluating e but not Surface Antigen Clearance. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2022. PMID: 35850413


  34. Khalili M, King WC, Kleiner DE, Chung RT, Bhan AK, Ghany MG, Sulkowski MS, Lisker-Melman M, Jain MK, Janssen HLA, Hinerman AS, Sanyal AJ, Sterling RK. Evolution of Fatty Liver Disease and Relationship With Lipoproteins and Clinical Outcomes in Hepatitis B/Human Immunodeficiency Virus Coinfection. 2021. PMID: 34698347


  35. Gizaw A, King WC, Hinerman AS, Chung RT, Lisker-Melman M, Ghany MG, Khalili M, Jain MK, Graham J, Swift-Scanlan T, Kleiner DE, Sulkowski M, Wong DK, Sterling RK, HIV-HBV Cohort Study of the Hepatitis B Research Network. A prospective cohort study of renal function and bone turnover in adults with hepatitis B virus (HBV)-HIV co-infection with high prevalence of tenofovir-based antiretroviral therapy use. 2022. PMID: 35578388


  36. Anderson ACT, Richards A, Delucchi K, Khalili M. Coverage, inequity and predictors of hepatitis B birth vaccination in Myanmar from 2011-2016: results from a national survey. 2022. PMID: 35436953


  37. Partida D, Powell J, Gonzalez D, Khalili M. Gaps in Hepatitis A and Hepatitis B Vaccination Among Hepatitis C Antibody-Positive Individuals Experiencing Homelessness. 2022. PMID: 35531381


  38. Khalili M, Kleiner DE, King WC, Sterling RK, Ghany MG, Chung RT, Bhan AK, Rosenthal P, Lisker-Melman M, Ramachandran R, Lok AS. Reply to Li, Henry, and Nguyen. 2022. PMID: 35158369


  39. Perrillo RP, Lin HS, Schwarz KB, Rosenthal P, Lisker-Melman M, Chung RT, Prokunina-Olsson L, Coherty G, Feld J, Hepatitis B Research Network (HBRN). Changes in serum hepatitis B surface and e antigen, IP-10, and aminotransferase levels during combination therapy of immune tolerant chronic hepatitis B. 2022. PMID: 35188674


  40. Partida D, Powell J, Ricco M, Naugle J, Magee C, Zevin B, Masson CL, Konadu Fokuo J, Gonzalez D, Khalili M. Formal Hepatitis C Education Increases Willingness to Receive Therapy in an On-site Shelter-Based HCV Model of Care in Persons Experiencing Homelessness. 2022. PMID: 35369281


  41. Powell J, Ricco M, Naugle J, Magee C, Hassan H, Masson C, Braimoh G, Zevin B, Khalili M. Erratum to: Adherence to Hepatitis C Therapy in a Shelter-Based Education and Treatment Model Among Persons Experiencing Homelessness. 2022. PMID: 35224129


  42. Li W, Syed F, Yu R, Yang J, Xia Y, Relich RF, Russell PM, Zhang S, Khalili M, Huang L, Kacena MA, Zheng X, Yu Q. Soluble Immune Checkpoints Are Dysregulated in COVID-19 and Heavy Alcohol Users With HIV Infection. 2022. PMID: 35281051


  43. Lok AS, Moon J, Sherman KE, Khalili M, Fishbein D, Reddy KR, PRIORITIZE Study Team. Long-term follow-up of hepatitis C patients who achieved sustained virologic response in the pragmatic PRIORITIZE Study. 2022. PMID: 35182741


  44. Terrault NA, Wahed AS, Feld JJ, Cooper SL, Ghany MG, Lisker-Melman M, Perrillo R, Sterling RK, Khalili M, Chung RT, Rosenthal P, Fontana RJ, Sarowar A, Lau DTY, Wang J, Lok AS, Janssen HLA. Incidence and prediction of HBsAg seroclearance in a prospective multi-ethnic HBeAg-negative chronic hepatitis B cohort. 2021. PMID: 34743343


  45. Thomas MD, Vittinghoff E, Crystal S, Walkup J, Olfson M, Khalili M, Dahiya P, Keenan W, Cournos F, Mangurian C. Hepatitis C Screening Among Medicaid Patients With Schizophrenia, 2002-2012. 2022. PMID: 35059641


  46. Khalili M, Kim NJ, Tsoh JY, Walsh JME, Goldman LE, Gildengorin G, Wong C, Tran MT, Yu E, Sharp MT, LeTran VH, Nguyen VV, Nguyen TT. Health Within Reach-a Patient-Centered Intervention to Increase Hepatitis B Screening Among Asian Americans: a Randomized Clinical Trial. 2022. PMID: 34993863


  47. Chung RT, King WC, Ghany MG, Lisker-Melman M, Hinerman AS, Khalili M, Sulkowski M, Jain MK, Choi EK, Nalesnik MA, Bhan AK, Cloherty G, Wong DK, Sterling RK, HBV-HIV Cohort Study of the Hepatitis B Research Network. A prospective cohort study of novel markers of hepatitis B virus replication in human immunodeficiency virus coinfection. 2021. PMID: 34973459


  48. Ghany MG, King WC, Lisker-Melman M, Sf Lok A, Terrault N, Janssen HLA, Khalili M, Chung RT, Lee WM, Lau DTY, Cloherty GA, Sterling RK. Letter to the Editor: HBcrAg and Prediction of Hepatocellular Carcinoma Risk. 2021. PMID: 34800047


  49. Kim RG, Medina SP, Magee C, Khalili M. Fatty Liver and the COVID-19 Pandemic: Health Behaviors, Social Factors, and Telemedicine Satisfaction in Vulnerable Populations. 2021. PMID: 34792300


  50. Kim RG, Kramer-Feldman J, Bacchetti P, Grimes B, Burchard E, Eng C, Hu D, Hellerstein M, Khalili M. Disentangling the impact of alcohol use and hepatitis C on insulin action in Latino individuals. 2021. PMID: 34773280


  51. Khalili M, King WC, Kleiner DE, Jain MK, Chung RT, Sulkowski M, Lisker-Melman M, Wong DK, Ghany M, Sanyal A, Sterling RK. Fatty Liver Disease in a Prospective North American Cohort of Adults with HIV and Hepatitis B Coinfection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020. PMID: 32869840


  52. Khalili M, Powell J, Park HH, Bush D, Naugle J, Ricco M, Magee C, Braimoh G, Zevin B, Fokuo JK, Masson CL. Shelter-Based Integrated Model Is Effective in Scaling Up Hepatitis C Testing and Treatment in Persons Experiencing Homelessness. 2021. PMID: 34628726


  53. Powell J, Ricco M, Naugle J, Magee C, Hassan H, Masson C, Braimoh G, Zevin B, Khalili M. Adherence to Hepatitis C Therapy in a Shelter-Based Education and Treatment Model Among Persons Experiencing Homelessness. 2021. PMID: 34651053


  54. Ghany MG, King WC, Lisker-Melman M, Lok ASF, Terrault N, Janssen HLA, Khalili M, Chung RT, Lee WM, Lau DTY, Cloherty GA, Sterling RK. Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America. 2021. PMID: 34133774


  55. Sulkowski MS, Moon JS, Sherman KE, Morelli G, Darling JM, Muir AJ, Khalili M, Fishbein DA, Hinestrosa F, Shiffman ML, Di Bisceglie A, Rajender Reddy K, Pearlman B, Lok AS, Fried MW, Stewart PW, Peter J, Wadsworth S, Kixmiller S, Sloan A, Vainorius M, Horne PM, Michael L, Dong M, Evon DM, Segal JB, Nelson DR, PRIORITIZE Study Team. A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study. 2021. PMID: 34255381


  56. Sterling RK, King WC, Khalili M, Chung RT, Sulkowski M, Jain MK, Lisker-Melman M, Ghany MG, Wong DK, Hinerman AS, Bhan AK, Wahed AS, Kleiner DE, HIV-HBV Cohort Study of the Hepatitis B Research Network. A Prospective Study Evaluating Changes in Histology, Clinical and Virologic Outcomes in HBV-HIV Co-infected Adults in North America. Hepatology (Baltimore, Md.) 2021. PMID: 33743541


  57. Lee WM, King WC, Janssen HLA, Ghany MG, Fontana RJ, Fried M, Sterling RK, Feld JJ, Wang J, Mogul DB, Cooper SL, Bisceglie AMD, Hepatitis B Research Network (HBRN). Hepatitis B e antigen loss in adults and children with chronic hepatitis B living in North America: A prospective cohort study. 2021. PMID: 34355475


  58. Khalili M, Kleiner DE, King WC, Sterling RK, Ghany MG, Chung RT, Bhan AK, Rosenthal P, Lisker-Melman M, Ramachandran R, Lok AS, ; and the Hepatitis B Research Network (HBRN). Hepatic Steatosis and Steatohepatitis in a Large North American Cohort of Adults With Chronic Hepatitis B. The American journal of gastroenterology 2021. PMID: 33840726


  59. Kim S, Powell J, Naugle J, Ricco M, Magee C, Masson C, Zevin B, Bush D, Khalili M. Patient-reported experiences with direct acting antiviral therapy in an integrated model of hepatitis C care in homeless shelters. 2021. PMID: 34003525


  60. Lok AS, Perrillo R, Lalama CM, Fried MW, Belle SH, Ghany MG, Khalili M, Fontana RJ, Sterling RK, Terrault N, Feld JJ, Di Bisceglie AM, Lau DTY, Hassan M, Janssen HLA,. medLow Incidence of Adverse Outcomes in Adults with Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy. Hepatology (Baltimore, Md.) 2020. PMID: 32936969


  61. Evon DM, Lin HS, Fontana RJ, Khalili M, Yim C, Wahed AS, Hoofnagle JH. Liver disease symptoms are associated with higher risk of adverse clinical outcomes: A longitudinal study of North American adults with chronic Hepatitis B. 2021. PMID: 34421369


  62. Cooper SL, King WC, Mogul DB, Ghany MG, Schwarz KB, Hepatitis B Research Network (HBRN). Clinical significance of quantitative e antigen in a cohort of hepatitis B virus-infected children and adults in North America. 2021. PMID: 33893706


  63. Lau DTY, Ganova-Raeva L, Wang J, Mogul D, Chung RT, Lisker-Melman M, Chang KM, Shaikh OS, Janssen HLA, Wahed AS, Lok AS. Precore and basal core promoter hepatitis B virus (HBV) variants are present from a young age and differ across HBV genotypes. Hepatology (Baltimore, Md.) 2020. PMID: 32860463


  64. Traum D, Wang YJ, Schwarz KB, Schug J, Wong DK, Janssen H, Terrault NA, Khalili M, Wahed AS, Murray KF, Rosenthal P, Ling SC, Rodriguez-Baez N, Sterling RK, Lau DT, Block TM, Feldman MD, Furth EE, Lee WM, Kleiner DE, Lok AS, Kaestner KH, Chang KM. Highly multiplexed 2-dimensional imaging mass cytometry analysis of HBV-infected liver. JCI insight 2021. PMID: 33621209


  65. Sterling RK, King WC, Khalili M, Kleiner DE, Hinerman AS, Sulkowski M, Chung RT, Jain MK, Lisker-Melman MA, Wong DK, Ghany MG. Performance of Serum-Based Scores for Identification of Mild Hepatic Steatosis in HBV Mono-infected and HBV-HIV Co-infected Adults. Digestive diseases and sciences 2021. PMID: 33559089


  66. Wong RJ, Saab S, Konyn P, Sundaram V, Khalili M. Rural-Urban Geographical Disparities in Hepatocellular Carcinoma Incidence Among US Adults, 2004-2017. The American journal of gastroenterology 2020. PMID: 32976121


  67. Powell J, Khalili M. Reply. Hepatology communications 2020. PMID: 33305157


  68. Kim NJ, Rozenberg-Ben-Dror K, Jacob DA, Rich N, Singal AG, Aby ES, Yang JD, Nguyen V, Pillai A, Fuchs M, Moon AM, Shroff H, Agarwal PD, Perumalswami P, Chandna S, Zhou K, Patel YA, Latt NL, Wong R, Duarte-Rojo A, Lindenmeyer CC, Frenette C, Ge J, Mehta N, Yao F, Benhammou JN, Bloom PP, Leise M, Kim HS, Levy C, Barnard A, Khalili M, Ioannou GN. Provider attitudes toward risk-based hepatocellular carcinoma surveillance in patients with cirrhosis in the U.S. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2020. PMID: 32927050


  69. Wong RJ, Khalili M. A Patient-Centered Hepatitis B Virus (HBV) Educational Intervention Improves HBV Care Among Underserved Safety-Net Populations. Journal of clinical gastroenterology 2019. PMID: 31688365


  70. Mangia A, Milligan S, Khalili M, Fagiuoli S, Shafran SD, Carrat F, Ouzan D, Papatheodoridis G, Ramji A, Borgia SM, Wedemeyer H, Losappio R, Pérez-Hernandez F, Wick N, Brown RS, Lampertico P, Doucette K, Ntalla I, Ramroth H, Mertens M, Vanstraelen K, Turnes J. Global real-world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: analysis of 5552 patients from 12 cohorts. Liver international : official journal of the International Association for the Study of the Liver 2020. PMID: 32449966


  71. Masson CL, Fokuo JK, Anderson A, Powell J, Zevin B, Bush D, Khalili M. Clients' perceptions of barriers and facilitators to implementing hepatitis C virus care in homeless shelters. BMC infectious diseases 2020. PMID: 32471376


  72. Lisker-Melman M, Khalili M, Belle SH, Terrault NA, Lin HS, Smith CI, Chung RT, Tsai N, Bzowej NH, Tran TT, Schwarzenberg SJ. Maternal knowledge of the risk of vertical transmission and offspring acquisition of hepatitis B. Annals of hepatology 2020. PMID: 32507734


  73. Mukhtar NA, Evon DM, Yim C, Lok AS, Lisha N, Lisker-Melman M, Hassan M, Janssen HLA, Khalili M. Patient Knowledge, Beliefs and Barriers to Hepatitis B Care: Results of a Multicenter, Multiethnic Patient Survey. Digestive diseases and sciences 2020. PMID: 32239377


  74. Fokuo JK, Masson CL, Anderson A, Powell J, Bush D, Ricco M, Zevin B, Ayala C, Khalili M. Recommendations for Implementing Hepatitis C Virus Care in Homeless Shelters: The Stakeholder Perspective. Hepatology communications 2020. PMID: 32363316


  75. Brahmania M, Liu S, Wahed AS, Yim C, Hansen BE, Khalili M, Terrault NA, Lok AS, Ghany M, Wang J, Wong D, Janssen HLA. Alcohol, tobacco and coffee consumption and liver disease severity among individuals with Chronic Hepatitis B infection in North America. Annals of hepatology 2020. PMID: 32139262


  76. Evon DM, Lin HS, Khalili M, Fontana RJ, Yim C, Wahed AS, Fried MW, Hoofnagle JH. Patient-reported outcomes in a large North American cohort living with chronic hepatitis B virus: a cross-sectional analysis. Alimentary pharmacology & therapeutics 2020. PMID: 31943262


  77. Younossi ZM, Ratziu V, Loomba R, Rinella M, Anstee QM, Goodman Z, Bedossa P, Geier A, Beckebaum S, Newsome PN, Sheridan D, Sheikh MY, Trotter J, Knapple W, Lawitz E, Abdelmalek MF, Kowdley KV, Montano-Loza AJ, Boursier J, Mathurin P, Bugianesi E, Mazzella G, Olveira A, Cortez-Pinto H, Graupera I, Orr D, Gluud LL, Dufour JF, Shapiro D, Campagna J, Zaru L, MacConell L, Shringarpure R, Harrison S, Sanyal AJ. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Lancet (London, England) 2019. PMID: 31813633


  78. Zhou K, Wahed AS, Cooper S, Di Bisceglie AM, Fontana RJ, Ghany MG, Khalili M, Lok AS, Perrillo R, Lee WM, Lau DTY, Sterling R, Janssen HLA, Terrault NA. Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level Viremia. The American journal of gastroenterology 2019. PMID: 31658127


  79. Sterling RK, King WC, Wahed AS, Kleiner DE, Khalili M, Sulkowski M, Chung RT, Jain MK, Lisker-Melman M, Wong DK, Ghany MG. Evaluating non-invasive markers to identify advanced fibrosis by liver biopsy in HBV/HIV coinfected adults. Hepatology (Baltimore, Md.) 2019. PMID: 31220357


  80. Bzowej NH, Tran TT, Li R, Belle SH, Smith CI, Khalili M, Chung R, Tsai N, Terrault N. Total Alanine Aminotransferase (ALT) Flares in Pregnant North American Women With Chronic Hepatitis B Infection: Results From a Prospective Observational Study. The American journal of gastroenterology 2019. PMID: 31082876


  81. Kim NJ, Holguin D, Bush D, Khalili M. Hepatitis C Screening in an Underserved U.S. Cohort of Reproductive Age Women. Hepatology communications 2019. PMID: 31497740


  82. Di Bisceglie AM, King WC, Lisker-Melman M, Khalili M, Belle SH, Feld JJ, Ghany MG, Janssen HLA, Lau D, Lee WM, Ling SC, Cooper S, Rosenthal P, Schwarz KB, Sterling RK, Teckman JH, Terrault N. Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B. Journal of viral hepatitis 2019. PMID: 30974509


  83. Sterling RK, Wahed AS, King WC, Kleiner DE, Khalili M, Sulkowski M, Chung RT, Jain MK, Lisker-Melman M, Wong DK, Ghany MG. Spectrum of Liver Disease in Hepatitis B Virus (HBV) Patients Co-infected with Human Immunodeficiency Virus (HIV): Results of the HBV-HIV Cohort Study. The American journal of gastroenterology 2018. PMID: 30410040


  84. Chang KM, Traum D, Park JJ, Ho S, Ojiro K, Wong DK, Wahed AS, Terrault NA, Khalili M, Sterling RK, Janssen HLA, Shuhart MC, Lau DT, Roberts LR, Johnson GS, Kaplan DE, Betts MR, Lee WM, Lok ASF. Distinct phenotype and function of circulating Vd1+ and Vd2+ ?dT-cells in acute and chronic hepatitis B. PLoS pathogens 2019. PMID: 30998783


  85. McGivern DR, Lin HS, Wang J, Benzine T, Janssen HLA, Khalili M, Lisker-Melman M, Fontana RJ, Belle SH, Fried MW. Prevalence and Impact of Hepatitis E Virus Infection Among Persons With Chronic Hepatitis B Living in the US and Canada. Open forum infectious diseases 2019. PMID: 31139669


  86. Feld JJ, Terrault NA, Lin HS, Belle SH, Chung RT, Tsai N, Khalili M, Perrillo R, Cooper SL, Ghany MG, Janssen HLA, Lok AS. Entecavir and Peginterferon Alfa-2a in Adults With Hepatitis B e Antigen-Positive Immune-Tolerant Chronic Hepatitis B Virus Infection. Hepatology (Baltimore, Md.) 2018. PMID: 30549279


  87. Brahmania M, Lombardero M, Hansen BE, Terrault NA, Lok AS, Perrillo RP, Belle SH, Di Bisceglie AM, Feld JJ, Lee WM, Fried MW, Janssen HLA. Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2019. PMID: 30743006


  88. Brouwer WP, Zhao Q, Hansen BE, Lau D, Khalili M, Terrault NA, Di Bisceglie AM, Perrillo RP, Fried MW, Wong D, Feld JJ, Belle SH, Janssen HLA. Improved Definition of HBV Phenotypes based on Genotype-specific Levels of Hepatitis B s Antigen. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2019. PMID: 30630104


  89. Khalili M, Wong RJ. Underserved Does Not Mean Undeserved: Unfurling the HCV Care in the Safety Net. Digestive diseases and sciences 2018. PMID: 30311153


  90. Kim NJ, Magee C, Cummings C, Park H, Khalili M. Liver Disease Monitoring Practices After Hepatitis C Cure in the Underserved Population. Hepatology communications 2018. PMID: 30288480


  91. Kim NJ, Locke CJ, Park H, Magee C, Bacchetti P, Khalili M. Race and Hepatitis C Care Continuum in an Underserved Birth Cohort. Journal of general internal medicine 2018. PMID: 30238404


  92. Lee B, Holt EW, Wong RJ, Sewell JL, Somsouk M, Khalili M, Maher JJ, Tana MM. Race/ethnicity is an independent risk factor for autoimmune hepatitis among the San Francisco underserved. Autoimmunity 2018. PMID: 29890851


  93. Beck KR, Kim NJ, Khalili M. Direct Acting Antivirals Improve HCV Treatment Initiation and Adherence Among Underserved African Americans. Annals of hepatology 2018. PMID: 29735789


  94. Khalili M, Shuhart MC, Lombardero M, Feld JJ, Kleiner DE, Chung RT, Terrault NA, Lisker-Melman M, Sanyal A, Lok AS. Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B. Diabetes care 2018. PMID: 29599296


  95. Uribe LA, Bacchetti P, Gelman N, Burchard E, Fitch M, Hellerstein M, Khalili M. Impact of Moderate Alcohol Discontinuation on Insulin Action and Secretion in Latinos With and Without Hepatitis C. Volume 42 of Issue 3. Alcoholism, clinical and experimental research 2018. PMID: 29220547


  96. Wen JW, Kohn MA, Wong R, Somsouk M, Khalili M, Maher J, Tana MM. Hospitalizations for Autoimmune Hepatitis Disproportionately Affect Black and Latino Americans. Volume 113 of Issue 2. The American journal of gastroenterology 2018. PMID: 29380822


  97. Méndez-Lagares G, Lu D, Chen C, Terrault N, Segal MR, Khalili M, Monto A, Shen H, Manos MM, Lanier LL, Ryan JC, McCune JM, Hartigan-O'Connor DJ. Memory T Cell Proliferation before Hepatitis C Virus Therapy Predicts Antiviral Immune Responses and Treatment Success. Volume 200 of Issue 3. Journal of immunology (Baltimore, Md. : 1950) 2017. PMID: 29263212


  98. Mukhtar NA, Kathpalia P, Hilton JF, Lau G, Yu A, Grumbach K, Nguyen TT, Chan D, Khalili M. Provider, Patient, and Practice Factors Shape Hepatitis B Prevention and Management by Primary Care Providers. Journal of clinical gastroenterology 2017. PMID: 27811627


  99. Lok AS, Ganova-Raeva L, Cloonan Y, Punkova L, Lin HS, Lee WM, Ghany MG. Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment. Journal of viral hepatitis 2017. PMID: 28581155


  100. Bourlière M, Gordon SC, Flamm SL, Cooper CL, Ramji A, Tong M, Ravendhran N, Vierling JM, Tran TT, Pianko S, Bansal MB, de Lédinghen V, Hyland RH, Stamm LM, Dvory-Sobol H, Svarovskaia E, Zhang J, Huang KC, Subramanian GM, Brainard DM, McHutchison JG, Verna EC, Buggisch P, Landis CS, Younes ZH, Curry MP, Strasser SI, Schiff ER, Reddy KR, Manns MP, Kowdley KV, Zeuzem S. Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection. The New England journal of medicine 2017. PMID: 28564569


  101. Di Bisceglie AM, Lombardero M, Teckman J, Roberts L, Janssen HL, Belle SH, Hoofnagle JH. Determination of hepatitis B phenotype using biochemical and serological markers. Journal of viral hepatitis 2016. PMID: 27917600


  102. Beck KR, Kim N, Khalili M. Sofosbuvir-Containing Regimens for Chronic Hepatitis C Are Successful in the Safety-Net Population: A Real-World Experience. Digestive diseases and sciences 2016. PMID: 27743164


  103. Burman BE, Bacchetti P, Khalili M. Moderate Alcohol Use and Insulin Action in Chronic Hepatitis C Infection. Digestive diseases and sciences 2016. PMID: 27007134


  104. Trager E, Khalili M, Masson CL, Vittinghoff E, Creasman J, Mangurian C. Hepatitis C Screening Rate Among Underserved Adults With Serious Mental Illness Receiving Care in California Community Mental Health Centers. Volume 106 of Issue 4. American journal of public health 2016. PMID: 26890183


  105. Evon DM, Wahed AS, Johnson G, Khalili M, Lisker-Melman M, Fontana RJ, Sarkar S, Reeve BB, Hoofnagle JH. Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN). Digestive diseases and sciences 2016. PMID: 26831489


  106. Park JJ, Wong DK, Wahed AS, Lee WM, Feld JJ, Terrault N, Khalili M, Sterling RK, Kowdley KV, Bzowej N, Lau DT, Kim WR, Smith C, Carithers RL, Torrey KW, Keith JW, Levine DL, Traum D, Ho S, Valiga ME, Johnson GS, Doo E, Lok AS, Chang KM. Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B. Gastroenterology 2015. PMID: 26684441


  107. Gonzales CA, Bacchetti P, Khalili M. Impact of gender and menopausal status on metabolic parameters in chronic hepatitis C infection. Journal of viral hepatitis 2015. PMID: 26554398


  108. Khalili M, Sanyal A. Is there a relationship between hepatitis B surface antibody status and diabetes? Journal of diabetes 2015. PMID: 26201556


  109. Khalili M, Lombardero M, Chung RT, Terrault NA, Ghany MG, Kim WR, Lau D, Lisker-Melman M, Sanyal A, Lok AS. Diabetes and prediabetes in patients with hepatitis B residing in North America. Hepatology (Baltimore, Md.) 2015. PMID: 26390278


  110. Schaeffer S, Khalili M. Reasons for HCV non-treatment in underserved African Americans: implications for treatment with new therapeutics. Annals of hepatology 2015. PMID: 25671833


  111. Wu AH, Khalili M. The birth and potential death of IL28B genotyping for hepatitis C therapy. Personalized medicine 2015. PMID: 29754535


  112. Mukhtar NA, Toy BC, Burman BE, Yu A, Chen AH, Berman P, Nguyen T, Chan D, Hammer H, McCulloch CE, Khalili M. Assessment of HBV preventive services in a medically underserved Asian and Pacific Islander population using provider and patient data. Journal of general internal medicine 2014. PMID: 25324148


  113. Burman BE, Bacchetti P, Ayala CE, Gelman N, Melgar J, Khalili M. Liver inflammation is a risk factor for prediabetes in at-risk latinos with and without hepatitis C infection. Liver international : official journal of the International Association for the Study of the Liver 2014. PMID: 25156890


  114. Shah SC, Kornak J, Khalili M. Depression is not associated with peripheral insulin resistance in patients with chronic hepatitis C infection. Journal of viral hepatitis 2014. PMID: 25196736


  115. Ghany MG, Perrillo R, Li R, Belle SH, Janssen HL, Terrault NA, Shuhart MC, Lau DT, Kim WR, Fried MW, Sterling RK, Di Bisceglie AM, Han SH, Ganova-Raeva LM, Chang KM, Lok AS. Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2014. PMID: 25010003


  116. Larios SE, Masson CL, Shopshire MS, Hettema J, Jordan AE, McKnight C, Young C, Khalili M, Seewald RM, Min A, Hengl N, Sorensen JL, Des Jarlais DC, Perlman DC. Education and counseling in the methadone treatment setting improves knowledge of viral hepatitis. Journal of substance abuse treatment 2013. PMID: 24462241


  117. Burman BE, Mukhtar NA, Toy BC, Nguyen TT, Chen AH, Yu A, Berman P, Hammer H, Chan D, McCulloch CE, Khalili M. Hepatitis B management in vulnerable populations: gaps in disease monitoring and opportunities for improved care. Digestive diseases and sciences 2013. PMID: 24052195


  118. Masson CL, Delucchi KL, McKnight C, Hettema J, Khalili M, Min A, Jordan AE, Pepper N, Hall J, Hengl NS, Young C, Shopshire MS, Manuel JK, Coffin L, Hammer H, Shapiro B, Seewald RM, Bodenheimer HC, Sorensen JL, Des Jarlais DC, Perlman DC. A randomized trial of a hepatitis care coordination model in methadone maintenance treatment. American journal of public health 2013. PMID: 23947319


  119. Khalili M, Stewart S. Hepatocellular screening in hepatitis-B infected Asian Americans. Journal of viral hepatitis 2013. PMID: 23730847


  120. Lubega S, Agbim U, Surjadi M, Mahoney M, Khalili M. Formal hepatitis C education enhances HCV care coordination, expedites HCV treatment and improves antiviral response. Liver international : official journal of the International Association for the Study of the Liver 2013. PMID: 23509897


  121. Mukhtar NA, Bacchetti P, Ayala CE, Melgar J, Christensen S, Maher JJ, Khalili M. Insulin sensitivity and variability in hepatitis C virus infection using direct measurement. Volume 58 of Issue 4. Digestive diseases and sciences 2012. PMID: 23086116


  122. Feldman MD, Steinauer JE, Khalili M, Huang L, Kahn JS, Lee KA, Creasman J, Brown JS. A mentor development program for clinical translational science faculty leads to sustained, improved confidence in mentoring skills. Clinical and translational science 2012. PMID: 22883616


  123. Brandman D, Bacchetti P, Ayala CE, Maher JJ, Khalili M. Impact of insulin resistance on HCV treatment response and impact of HCV treatment on insulin sensitivity using direct measurements of insulin action. Volume 35 of Issue 5. Diabetes care 2012. PMID: 22399695


  124. Sarkar M, Stewart S, Yu A, Chen MS, Nguyen TT, Khalili M. Hepatocellular carcinoma screening practices and impact on survival among hepatitis B-infected Asian Americans. Journal of viral hepatitis 2012. PMID: 22762144


  125. Mukhtar NA, Ayala C, Maher JJ, Khalili M. Assessment of factors associated with pre-diabetes in HCV infection including direct and dynamic measurements of insulin action. Volume 19 of Issue 7. Journal of viral hepatitis 2011. PMID: 22676360


  126. Melia MT, Muir AJ, McCone J, Shiffman ML, King JW, Herrine SK, Galler GW, Bloomer JR, Nunes FA, Brown KA, Mullen KD, Ravendhran N, Ghalib RH, Boparai N, Jiang R, Noviello S, Brass CA, Albrecht JK, McHutchison JG, Sulkowski MS. Racial differences in hepatitis C treatment eligibility. Hepatology (Baltimore, Md.) 2011. PMID: 21488082


  127. Khalili M, Guy J, Yu A, Li A, Diamond-Smith N, Stewart S, Chen M, Nguyen T. Hepatitis B and hepatocellular carcinoma screening among Asian Americans: survey of safety net healthcare providers. Digestive diseases and sciences 2010. PMID: 21046247


  128. Surjadi M, Torruellas C, Ayala C, Yee HF, Khalili M. Formal patient education improves patient knowledge of hepatitis C in vulnerable populations. Volume 56 of Issue 1. Digestive diseases and sciences 2010. PMID: 20972850


  129. Sulkowski MS, Shiffman ML, Afdhal NH, Reddy KR, McCone J, Lee WM, Herrine SK, Harrison SA, Poordad FF, Koury K, Deng W, Noviello S, Pedicone LD, Brass CA, Albrecht JK, McHutchison JG. Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate. Gastroenterology 2010. PMID: 20723545


  130. Lam KD, Bacchetti P, Abbasi F, Ayala CE, Loeb SM, Shah V, Wen MJ, Reaven GM, Maher JJ, Khalili M. Comparison of surrogate and direct measurement of insulin resistance in chronic hepatitis C virus infection: impact of obesity and ethnicity. Volume 52 of Issue 1. Hepatology (Baltimore, Md.) 2010. PMID: 20578127


  131. Terrault N, Khalili M. A glimpse of future hepatitis C virus treatment paradigms. Hepatology (Baltimore, Md.) 2010. PMID: 20104511


  132. McHutchison JG, Lawitz EJ, Shiffman ML, Muir AJ, Galler GW, McCone J, Nyberg LM, Lee WM, Ghalib RH, Schiff ER, Galati JS, Bacon BR, Davis MN, Mukhopadhyay P, Koury K, Noviello S, Pedicone LD, Brass CA, Albrecht JK, Sulkowski MS. Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection. The New England journal of medicine 2009. PMID: 19625712


  133. Kuo A, Tan V, Lan B, Khalili M, Feng S, Roberts JP, Terrault NA. Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2008. PMID: 18825708


  134. Khalili M. Coinfection with Hepatitis Viruses and HIV Update. In: Peiperl L, Volberding PA, eds. HIV InSite Knowledge Base [textbook on-line] Coinfection with Hepatitis Viruses and HIV Update. In: Peiperl L, Volberding PA, eds. HIV InSite Knowledge Base [textbook on-line] 2006. PMID:


  135. Khalili M, Vardanian AJ, Hamerski CM, Wang R, Bacchetti P, Roberts JP, Terrault NA. Management of hepatitis C-infected liver transplant recipients at large North American centres: changes in recent years. Volume 20 of Issue 1. Clinical transplantation 2006. PMID: 16556146


  136. Khalili M, Bernstein D, Lentz E, Barylski C, Hoffman-Terry M. Pegylated interferon alpha-2a with or without ribavirin in HCV/HIV coinfection: partially blinded, randomized multicenter trial. Digestive diseases and sciences 2005. PMID: 15986873


  137. Shergill AK, Khalili M, Straley S, Bollinger K, Roberts JP, Ascher NA, Terrault NA. Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation. Volume 5 of Issue 1. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005. PMID: 15636619


  138. Beatty G, Chu J, Kulkarni K, Lipshutz G, Khalili M, Abbasi F, Stansell J, Reaven GM. Relative effects of insulin resistance and protease inhibitor treatment on lipid and lipoprotein metabolism in HIV-infected patients. HIV clinical trials 2004. PMID: 15682351


  139. Khalili M, Proietti N. Treatment of the hepatitis C virus in patients coinfected with HIV. Gastroenterology clinics of North America 2004. PMID: 15324939


  140. Sulkowski MS, Felizarta F, Smith C, Slim J, Berggren R, Goodman R, Ball L, Khalili M, Dieterich DT. Daily versus thrice-weekly interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected persons: a multicenter randomized controlled trial. Journal of acquired immune deficiency syndromes (1999) 2004. PMID: 15021311


  141. Khalili M, Lim JW, Bass N, Ascher NL, Roberts JP, Terrault NA. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2004. PMID: 15004760


  142. Chu JW, Abbasi F, Beatty GW, Khalili M, Koch J, Rosen A, Schmidt JM, Stansell JD, Reaven GM. Methods for quantifying insulin resistance in human immunodeficiency virus-positive patients. Metabolism: clinical and experimental 2003. PMID: 12870161


  143. Beatty G, Khalili M, Abbasi F, Chu J, Reaven GM, Rosen A, Schmidt JM, Stansell J, Koch J. Quantification of insulin-mediated glucose disposal in HIV-infected individuals: comparison of patients treated and untreated with protease inhibitors. Journal of acquired immune deficiency syndromes (1999) 2003. PMID: 12792353


  144. Khalili M. Peiperl L, Volberding PA, eds. HIV InSite Knowledge Base [textbook on-line] Coinfection with Hepatitis Viruses and HIV Update 2003. PMID:


  145. Khalili M, Behm BW. Hepatitis C in the setting of HIV co-infection. Microbes and infection 2002. PMID: 12467766


  146. Khalili MA, Diestelhorst M, Krieglstein GK. [Long-term follow-up of 700 trabeculectomies]. 2000. PMID: 10949810


  147. Khalili M, Denham C, Perrillo R. Interferon and ribavirin versus interferon and amantadine in interferon nonresponders with chronic hepatitis C. The American journal of gastroenterology 2000. PMID: 10811340


  148. Khalili M, Perrillo RP. Clinics in Liver Disease Interferon Therapy of Hepatitis B 1999. PMID:


  149. Diestelhorst M, Khalili MA, Krieglstein GK. Trabeculectomy: a retrospective follow-up of 700 eyes. International ophthalmology 1998. PMID: 10674865


  150. Walley VM, Keon CA, Khalili M, Moher D, Campagna M, Keon WJ. Ionescu-Shiley valve failure. I: Experience with 125 standard-profile explants. The Annals of thoracic surgery 1992. PMID: 1610221


  151. Walley VM, Keon CA, Khalili M, Moher D, Campagna M, Keon WJ. Ionescu-Shiley valve failure. II: Experience with 25 low-profile explants. The Annals of thoracic surgery 1992. PMID: 1610222


  152. Wolfsohn AL, Walley VM, Davies RA, Keon CA, Khalili M, Keon WJ. The University of Ottawa Heart Institute Cardiac Transplant Program: the first 100 transplants. A pathologic study of the explanted hearts. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1992. PMID: 1574494